loading
前日終値:
$21.95
開ける:
$21.87
24時間の取引高:
183.61K
Relative Volume:
0.38
時価総額:
$1.04B
収益:
-
当期純損益:
$-85.21M
株価収益率:
-11.22
EPS:
-1.89
ネットキャッシュフロー:
$-68.53M
1週間 パフォーマンス:
-6.44%
1か月 パフォーマンス:
-1.40%
6か月 パフォーマンス:
-3.02%
1年 パフォーマンス:
-15.27%
1日の値動き範囲:
Value
$21.04
$22.45
1週間の範囲:
Value
$21.04
$23.41
52週間の値動き範囲:
Value
$13.30
$30.03

Enliven Therapeutics Inc Stock (ELVN) Company Profile

Name
名前
Enliven Therapeutics Inc
Name
セクター
Healthcare (1164)
Name
電話
720-647-8519
Name
住所
6200 LOOKOUT ROAD, BOULDER
Name
職員
65
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ELVN's Discussions on Twitter

ELVN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ELVN
Enliven Therapeutics Inc
21.20 1.29B 0 -85.21M -68.53M -1.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-16 開始されました Goldman Buy
2024-12-13 開始されました BTIG Research Buy
2024-09-09 開始されました H.C. Wainwright Buy
2024-06-11 開始されました Robert W. Baird Outperform
2024-04-09 開始されました Mizuho Buy
2023-03-29 開始されました Jefferies Buy
すべてを表示

Enliven Therapeutics Inc (ELVN) 最新ニュース

pulisher
Jul 25, 2025

What drives Enliven Therapeutics Inc. stock priceTremendous wealth creation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What risks could impact Enliven Therapeutics Inc. stock performanceMarket-beating returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Will Enliven Therapeutics Inc. stock split in the near futureMoney Making Low Risk Plans - Newser

Jul 25, 2025
pulisher
Jul 24, 2025

Polis encourages life-sciences companies to move to Colorado - BizWest

Jul 24, 2025
pulisher
Jul 23, 2025

Enliven Therapeutics Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Enliven Therapeutics Inc. stockOutstanding investment returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Enliven Therapeutics Inc. a good long term investmentTriple-digit growth rates - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Enliven Therapeutics CSO sells $278k in shares - Investing.com Australia

Jul 23, 2025
pulisher
Jul 23, 2025

Enliven Therapeutics’ Promising CML Study Update: What Investors Need to Know - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Samuel Kintz Sells 12,500 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

Why Enliven Therapeutics Inc. stock attracts strong analyst attentionDaily Price Surge List - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

Can Enliven Therapeutics, Inc. (ELVN) Climb 75.66% to Reach the Level Wall Street Analysts Expect? - MSN

Jul 20, 2025
pulisher
Jul 19, 2025

Enliven Therapeutics’ Promising Phase 1a/1b Study on ELVN-002 in HER2+ Cancers - The Globe and Mail

Jul 19, 2025
pulisher
Jul 19, 2025

Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Enliven Therapeutics (ELVN) - The Globe and Mail

Jul 19, 2025
pulisher
Jul 17, 2025

Enliven Therapeutics’ Promising CML Treatment: A Study Update - TipRanks

Jul 17, 2025
pulisher
Jul 15, 2025

What makes Enliven Therapeutics Inc. stock price move sharplyFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Enliven Therapeutics Inc. stock performs during market volatilityInsider Strategy Insight - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

(ELVN) Proactive Strategies - news.stocktradersdaily.com

Jul 15, 2025
pulisher
Jul 15, 2025

Enliven Therapeutics CFO Hohl sells $22,655 in shares - Investing.com Australia

Jul 15, 2025

Enliven Therapeutics Inc (ELVN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Enliven Therapeutics Inc (ELVN) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Kintz Samuel
PRESIDENT AND CEO
Jul 17 '25
Sale
22.52
12,500
281,518
940,392
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):